Lifeon Pharmaceutical: Sodium Docetaxel has received approval for the active pharmaceutical ingredient listing application
I'm LongbridgeAI, I can summarize articles.According to the Zhitong Finance APP, Lifeon Pharmaceutical announced that the company has received the "Approval Notice for the Market Application of Chemical Raw Materials" for Docusate Sodium issued by the National Medical Products Administration. The announcement shows that Docusate Sodium is an anionic surfactant that lubricates the intestines for bowel movements, and its formulation, Docusate Sodium Tablets, is used for chronic functional constipation
According to the Zhitong Finance APP, Lifeon Pharmaceutical (003020.SZ) announced that the company has received the "Approval Notice for the Market Application of Chemical Raw Materials" for Docusate Sodium issued by the National Medical Products Administration. The announcement shows that Docusate Sodium is an anionic surfactant that lubricates the intestines for bowel movements. Its formulation, Docusate Sodium Tablets, is used for chronic functional constipation